Evidence map›Paper›PMID 30245721›Full record

ArticleInternational journal of analytical chemistry2018

Quantitative Detection of miRNA-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon.

Qingxin Liu, Jialong Fan, Chuang Zhou, Liqun Wang, Bin Zhao, Haibin Zhang, Bin Liu, Chunyi Tong

Erratum issuedAbstract read
In one paragraph

Article in International journal of analytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer.International journal of molecular sciences · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Qingxin LiuCollege of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu 210095, China.
Jialong FanCollege of Biology, Hunan University, Changsha, Hunan 410082, China.
Chuang ZhouJiangsu Vocational College of Agriculture and Forestry, Jurong, Jiangsu 212400, China.
Liqun WangJiangsu Vocational College of Agriculture and Forestry, Jurong, Jiangsu 212400, China.
Bin ZhaoCollege of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu 210095, China.
Haibin ZhangCollege of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu 210095, China.ORCID 0000-0001-8272-1562
Bin LiuCollege of Biology, Hunan University, Changsha, Hunan 410082, China.
Chunyi TongCollege of Biology, Hunan University, Changsha, Hunan 410082, China.ORCID 0000-0003-1153-5791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a new tumor marker, the microRNA-21 (miRNA21) level can provide important information for early diagnosis, drug treatment, and prognosis of gastric cancer. With the tool of molecular beacons which can hybridize specifically with target miRNA-21 and generate fluorescence signal change, this paper develops a direct, simple, and rapid method for miRNA-21 detection with detection limit of 0.5 nM. Under the optimal conditions, the method was used to detect the expression of miRNA-21 in tumor cells and tissues. The results showed significant differences of miRNA-21 levels in tumor cells which have different origins and different degree of malignancy. In 8 cases of gastric cancer tissues and adjacent tissues, the level of miRNA-21 in 6 cases was higher than that in adjacent tissues, 1 case had lower expression level than that in adjacent tissues, and 1 case had no significant difference. Furthermore, qRT-PCR method was used to verify the detection results based on the fluorescent probe detection method. The consistent results show that the molecular beacon assay has a good prospect in direct and rapid detection of miRNA-21 expression and will be widely used in the functional research and clinical diagnosis of microRNA.

Identifiers

PMID30245721
PMCPMC6139239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.